Where molecules dream of becoming adjuvants and pipettes are always calibrated (mostly).
Our team of highly caffeinated scientists spend their days convincing atoms to hold hands in very specific configurations. It's like molecular matchmaking, but with more safety goggles and fewer roses.
We've published over 47 papers, most of which have been read by at least 3 people outside our immediate families. Our h-index is "impressive enough to mention at dinner parties but not so high that anyone asks follow-up questions."
Through years of trial, error, more error, coffee, and the occasional "eureka!" moment at 2 AM, we've developed synthetic routes that make QS-21 without bothering a single tree. The Chilean soapbark trees send us thank-you cards every Christmas.
Our 14-step synthesis is so precise that if you mess up step 7, you don't get an adjuvant — you get a very expensive puddle. Ask us how we know.
Our adjuvants have been tested in 12 preclinical studies, 4 clinical trials, and one very confused undergraduate thesis that somehow cited us as a source on Renaissance art. We didn't correct them.
Key finding: Synthetic QS-21-Api elicits immune responses that are "statistically significant" — which in science speak means "we can finally stop re-running this experiment at midnight."